Trial Search
Current Search Criteria:
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
PHASE2Persistent viral infection with viral reservoirs and detection of circulati...
Status
Active Not Recruiting
Location
UCSF/Zuckerberg San Francisco General Hospital
Start Date
2024-04-09
Trial ID
NCT06161688
Treatments Being Tested
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
PHASE2The overall goal of this study is to determine the clinical benefit and saf...
Status
Terminated
Location
Lucile Packard Children's Hospital
Start Date
2018-08-31
Trial ID
NCT03107871
Treatments Being Tested
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment
PHASE3The main purpose of this study is to evaluate the efficacy of ixekizumab co...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2016-01-20
Trial ID
NCT02634801
Treatments Being Tested
Swiss Dermatology Network of Targeted Therapies (SDNTT)
N/AThe purpose of this study is to evaluate the long-term course of patients w...
Status
Recruiting
Location
Aarau Cantonal Hospital
Start Date
2011-02
Trial ID
NCT01706692
Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar Psoriasis
PHASE3The purpose of this prospective, randomized, controlled, single-blinded inv...
Status
Unknown
Location
Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology
Start Date
2008-10
Trial ID
NCT00811005
Treatments Being Tested
A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
PHASE3The purpose of the study is to compare the efficacy of Guselkumab with comm...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-12
Trial ID
NCT02951533
Treatments Being Tested
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PHASE1This phase 1 trial studies the side effects and best dose of dimethyl fumar...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-02-13
Trial ID
NCT02337426
Treatments Being Tested
Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)
PHASE3This is an open-label, multicenter, parallel-group comparison study of the ...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00254982
Treatments Being Tested
APremilast After FumaRic Acid Ester Treatment
N/APatient treatment preference and treatment satisfaction of physicians and p...
Status
Completed
Location
Site
Start Date
2017-01-26
Trial ID
NCT02954081
Treatments Being Tested
A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
PHASE4The primary objective is to demonstrate added benefit of brodalumab versus ...
Status
Completed
Location
Fachklinik Bad Bentheim Klinik für Dermatologie
Start Date
2017-11-03
Trial ID
NCT03331835
Treatments Being Tested